These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26213212)

  • 1. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.
    Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; Laan BF; van Criekinge W; de Meyer T; Denil S; van der Vegt B; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2016 Sep; 11(9):653-663. PubMed ID: 27379752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
    Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
    Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene promoter methylation of E-cadherin, p16
    Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
    Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT.
    Jensen GL; Axelrud G; Fink D; Hammonds K; Walker K; Volz M; Gowan A; Rao A; Deb N; Jhavar SG
    Radiother Oncol; 2021 Apr; 157():234-240. PubMed ID: 33577867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
    Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
    Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
    Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
    Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
    Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms.
    Schmitt AM; Pavel M; Rudolph T; Dawson H; Blank A; Komminoth P; Vassella E; Perren A
    Neuroendocrinology; 2014; 100(1):35-44. PubMed ID: 25012122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma.
    Wei DM; Liu DY; Lei DP; Jin T; Wang J; Pan XL
    Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.